November 23, 2009

Commentary: So much for drug companies' promises

Is the support of the pharmaceutical industry needed for Congress to pass health care reform? Or is the price of that support too high for the people the reform package is trying to help? Those questions took on new urgency with the release of an AARP study finding that drug makers had raised the wholesale price of brand-name drugs by 9%, or $10 billion, in the past year. That's the biggest price increase in 17 years.

Related content


Editor's Choice Videos